One-Year Results of the Use of Absorb Bioresorbable Vascular Scaffold in Patients with Different Forms of Coronary Artery Disease as Compared to a Drug-Eluting Stent
| Autor: | Robert J. Gil, Nabijon Yuldashev, Ravshanbek D. Kurbanov |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
General Immunology and Microbiology business.industry General Neuroscience medicine.medical_treatment lcsh:R lcsh:Medicine medicine.disease General Biochemistry Genetics and Molecular Biology Coronary artery disease Drug-eluting stent Internal medicine drug-eluting stent Cardiology Medicine In patient cardiovascular diseases business Absorb bioresorbable vascular scaffold coronary artery disease Bioresorbable vascular scaffold |
| Zdroj: | International Journal of Biomedicine, Vol 8, Iss 1, Pp 20-25 (2018) |
| ISSN: | 2158-0529 2158-0510 |
| DOI: | 10.21103/article8(1)_oa2 |
| Popis: | The aim of this study was to evaluate the immediate and long-term (12 months) clinical and angiographic efficacy of myocardial revascularization using Absorb GT1 Bioresorbable Vascular Scaffold (BVS) in comparison to second-generation drug-eluting stent (DES) in patients with various forms of coronary artery disease (CAD). Material and Methods: The study included 152 patients with CAD. There were 131 men and 32 women with an average age of 54.6±10.4 years. Patients' data were evaluated retrospectively from the medical records. Results: • Implantation of BVS in patients with different forms of CAD did not cause any angiographic or clinical complications, either at the hospital or at 12-month observation stages, and the results were comparable to those of the DES group. • The technique of implanting BVS and the reception of dual antiplatelet therapy are the key factors for achieving positive results in real clinical practice. • The use of BVS-frameworks contributes to improving clinical, functional and laboratory indicators, while the observed positive dynamics are comparable to similar data of the DES group. • Regardless of the type of implanted stents, the survival rate among CAD patients within 12 months after stenting was 100%, while none of the respondents during this time developed acute MI or recurrence of angina attacks. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|